| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8349630 | Pharmacological Reports | 2018 | 9 Pages |
Abstract
Substantially, DEAE-Dextran leads to anti-tumor activity through anti-angiogenic action and a combination of in vitro and in vivo model is vital for the judgement of anti-angiogenic potential since an in vitro model exempts mammalian-culture considerations.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Anita K. Bakrania, Bhavesh C. Variya, Snehal S. Patel,